Japan's Ministry of Health, Labour and Welfare Approves CSL and Arcturus Therapeutics' ARCT-154, the first Self-Amplifying mRNA vaccine approved for COVID in adults

Exclusive Partner in Japan, Meiji Seika Pharma advances regulatory approval
This historic approval of the world's first Self-Amplifying messenger RNA COVID-19 Vaccine underscores CSL's promise to...

Related Keywords

Meiji ,Hokkaido ,Japan ,China ,Australia ,Vietnam ,Republic Of ,California ,United States ,San Diego ,Kim Odonohue ,Neda Safarzadeh ,Seika Pharma ,Hamish Walsh ,Joseph Payne ,Stephen Marlow ,Jonathan Edelman ,Asia Pacific ,Japan Ministry Of Health ,Arcturus Therapeutics Holdings Inc ,Nasdaq ,Mrna Technology ,Linkedin ,Twitter ,Exclusive Partner ,Meiji Seika Pharma ,Arcturus Therapeutics ,Global Collaboration ,Drew Weissman ,Senior Vice President ,Vaccines Innovation Unit ,Chief Executive Officer ,General Manager ,Arcturus Therapeutics Holdings ,Media Contact ,Markets ,